A paper on CTLA-4-binding cyclic peptides and their peptidomimetic small molecules has been published.
A paper on CTLA-4-binding cyclic peptides and their peptidomimetic small molecules by joint research by GeneFrontier and PRISM BioLab has been publ...
[Important] Notice of Material Change for Solution I
We would like to inform that the material for Solution I contained in PUREfrex® kits will be changed because the material we have been using is to ...
Presentation: PEGS Boston
May 2 – 6, 2022, Boston, MA & ONLINE PEGS Boston: Conference & Expo Stop by booth #1218 to meet our latest Rebuilding the Cell Free...
May 11 – 13, 2021, Boston, MA PEGS: the essential protein engineering summit Our presentation at 2:50 pm EDT on May 12, Engineering Bispecific Anti...
Booth and Poster: Cell Free Systems Conference
Cell Free Systems Conference December 4-6, 2019, Boston, MA U.S.A. GeneFrontier presented our latest data in the poster session. Poster title “Synt...
Poster: PEGS Boston
April 08 – 12, 2019, Boston, MA PEGS: the essential protein engineering summit GeneFrontier presented our latest data in the poster session regardi...
GeneFrontier presented poster is available. Poster Title: Unique Cell-Free Protein Synthesis System, PUREfrex: Useful Platform for Protein Expressi...
PUREfrex®2.1 is newly launched
PUREfrex®2.1 is newly launched in December 2017. The selection of the suitable reducing agent and its ratio with oxidizing agent is very important...